Ocumension Therapeutics Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2021
September 20, 2021 at 04:45 am EDT
Ocumension Therapeutics reported unaudited consolidated earnings results for the six months ended June 30, 2021. For the six months, the company announced revenue of RMB 20,803,000 compared to RMB 1,952,000 a year ago. Loss for the period was RMB 69,609,000 compared to RMB 1,741,770,000 a year ago. Basic and diluted loss per share was RMB 0.12 compared to RMB 27 a year ago.